Blow for Novo Nordisk with phase 3 kidney disease drug failure
Kidney disease and hypertension therapy late-stage failure will cost the Danish big pharma more than US $800 million
Archives for June 27, 2024
EvolutionaryScale raises $142M and launches AI model for protein discovery
The new generative AI model released by EvolutionaryScale will be used by researchers and pharma companies to empower drug discovery.
TVM Capital Healthcare invests $35m in Saudi generics and biosimilars
As Saudi Arabia seeks to make its healthcare system more cost-efficient, the private equity firm TVM Capital Healthcare is betting $35 million on the Saudi Arabia-based bio-generics provider Boston Oncology Arabia.
Purolite's launch of innovative DurA Cycle A50 resin, expanding market impact at BIO 2024
At BIO 2024, Purolite made waves in the biopharmaceutical industry with the launch of their innovative DurA Cycle A50 resin.